InsidersTradesSigma
Discover the detailed record of transactions filed by Mullins Kevin Michael, Directeur du Développement. Officer active across 1 companies, notably LifeStance Health Group, Inc.. Cumulatively, 3 disclosures have been recorded. Total volume traded: €857k. The latest transaction was filed on 13 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Mullins Kevin Michael is the Chief Development Officer at LifeStance Health Group, Inc. He is responsible for the company's development strategy, including service and operational expansion. His role is essential in supporting growth and innovation within the company.